Altasciences Company Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Altasciences Company Inc. - overview
Established
1992
Location
Laval, QC, Canada
Primary Industry
Pharmaceuticals
About
Altasciences Company Inc. , based in Laval, Canada, functions as a contract research organization (CRO) specializing in early-phase drug development services, including preclinical evaluations and clinical trials. Founded in 1992, Altasciences Company Inc. is a contract research organization providing comprehensive services in drug development.
The company has undergone strategic developments, notably being acquired by Novo Holdings from Audax Private Equity in February 2021. The firm is headquartered in Laval, Canada, and led by CEO Chris Perkin. Altasciences offers a wide range of services as a mid-size contract research organization (CRO), focusing on early-phase drug development. Their core services include preclinical safety testing, clinical trials from Phase I to II, and bioanalytical services, catering primarily to biopharmaceutical companies in North America and Europe across therapeutic areas like cardiology and oncology.
In 2017, Altasciences reported a revenue of USD 75. 5 mn, with an EBITDA of USD 15. 1 mn, generated through a B2B model that emphasizes contracts for specific studies and comprehensive programs with clients. Following the acquisition by Novo Holdings in February 2021, Altasciences plans to leverage this investment to support its growth trajectory and expand both domestically and internationally.
The company aims to refine its service offerings and explore new geographic markets to enhance its operational reach.
Current Investors
Novo Holdings
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.altasciences.com
Company Stage
Mature
Total Amount Raised
Subscriber access only
Altasciences Company Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, LP Direct | Completed | Sinclair Research Center, LLC | - | ||||||||
| Add-on, LP Direct | Completed | Calvert Laboratories | - | ||||||||
| LP Direct, Trade Sale | Completed | Altasciences Company Inc. | - | ||||||||
| Add-on, Trade Sale | Completed | WCCT Global, Inc. | - | ||||||||
| Secondary Buyout | Completed | Altasciences Company Inc. | - |
Displaying 1 - 5 of 7
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.